3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
11
Phase 3
1
Phase 2/3
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
9
Breast Neoplasms
7
Neoplasms
4
Fatigue
3
Recurrence
2
Body Weight
2
Weight Loss
1
Warts
1
Vomiting
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Nausea
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Insulin Resistance
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Dementia
1
Colonic Neoplasms
1
Cognitive Dysfunction
1
Asthenia
1
Anomia
1
Alzheimer Disease
1
Interventions
Fluorouracil
72
Leucovorin
71
Oxaliplatin
47
Irinotecan
31
Capecitabine
24
Bevacizumab
23
Folfox protocol
20
Cetuximab
15
Chemotherapy, Adjuvant
13
Celecoxib
7
Aspirin
6
Laparoscopy
5
XELOX
4
Panitumumab
4
Neoadjuvant Therapy
4
Levamisole
4
dehydroftorafur
3
Tegafur
3
Surgical Procedures, Operative
3
Observation
3
Floxuridine
3
vatalanib
2
tislelizumab
2
pertuzumab
2
encorafenib
2
atezolizumab
2
Trastuzumab
2
Standard of Care
2
Semaxinib
2
Selenium
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Colonic Neoplasms
×
Exercise
×
Clear all
NCT04488159
2024-09-20
iMAGINE
Medical University of Vienna
Phase 3
Withdrawn